DarioHealth Corp. (DRIO) Earnings Call Analysis

NASDAQ · Healthcare · Health Information Services

23/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 3

latest quarter score

Earnings Reports

23
Dario Health (DRIO) Q2 2026: Contracted ARR Hits $13.1M with Multi-Condition Expansion Driving Long-Term Growth
August 11, 2026
23
Dario Health (DRIO) Q1 2026: Channel Reach Expands to 175M Covered Lives, Unlocking Platform Scale
June 17, 2026
20
DarioHealth (DRIO) Q2 2025: Gross Margin Jumps 11 Points as AI-Driven Cost Cuts Reshape Path to Profitability
June 16, 2026
20
Dario Health (DRIO) Q3 2025: 31% Operating Expense Cut Accelerates Shift to High-Margin Recurring Revenue
June 16, 2026
22
DarioHealth (DRIO) Q4 2025: Commercial Pipeline Doubles to $122M, Multi-Condition Model Drives Scale
June 16, 2026
23
DarioHealth (DRIO) Q1 2025: 17% Revenue Growth Underscores Multi-Condition Platform Momentum Amid Client Transition
May 14, 2025
22
DarioHealth (DRIO) Q4 2024: 110% Revenue Growth Highlights GLP-1 and Multi-Condition Platform Momentum
March 10, 2025

Browse all companies